Septic Shock

• FDA approval · 2025-06-03
  FDA Approved: ANGIOTENSIN II — Original Application (Gland Pharma Limited)

  FDA approved Gland Pharma Limited's Angiotensin II under an Original Application (ANDA216966).

• FDA approval · 2025-03-21
  FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (BIOCON PHARMA INC.)

  FDA approved Biocon Pharma Inc. for an Original Application of norepinephrine bitartrate (norepinephrine bitartrate) as a generic product. I…

• FDA approval · 2025-01-31
  FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Camber Pharmaceuticals, Inc.)

  FDA approves Camber Pharmaceuticals' norepinephrine bitartrate as an original application (generic) product.

• FDA approval · 2024-12-03
  FDA Approved: NOREPINEPHRINE — Supplemental Application (Long Grove Pharmaceuticals, LLC)

  FDA approved a supplemental application for norepinephrine bitartrate (NOREPINEPHRINE) from Long Grove Pharmaceuticals, LLC under NDA 214628…

• FDA approval · 2024-07-11
  FDA Approved: VASOPRESSIN IN 0.9% SODIUM CHLORIDE — Original Application (Long Grove Pharmaceuticals, LLC)

  FDA approved VASOPRESSIN IN 0.9% SODIUM CHLORIDE from Long Grove Pharmaceuticals as an original NDA for vasopressin injection to be used as …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2024-06-11
  FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved a supplemental application for norepinephrine bitartrate from Baxter Healthcare Corporation.

• FDA approval · 2023-09-29
  FDA Approved: VASOPRESSIN IN 0.9% SODIUM CHLORIDE — Original Application (Baxter Healthcare Corporation)

  The FDA granted approval for Baxter’s vasopressin in 0.9% sodium chloride under an Original Application (NDA).

• FDA approval · 2023-07-21
  FDA Approved: VASOPRESSIN — Supplemental Application (Amneal Pharmaceuticals LLC)

  FDA approves Amneal's supplemental application for Vasopressin under ANDA212944, authorizing changes to the approved generic product.

• FDA approval · 2022-09-15
  FDA Approved: NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE — Original Application (WG Critical Care, LLC)

  FDA approves norepinephrine bitartrate in sodium chloride for injection under an original application by WG Critical Care, LLC, a vasopresso…

• FDA approval · 2022-08-15
  FDA Approved: VASOPRESSIN — Original Application (Eugia US LLC)

  FDA approved the original application for VASOPRESSIN from Eugia US LLC, a generic vasopressin product. It is indicated for use as a vasopre…

• FDA approval · 2022-08-05
  FDA Approved: VASOPRESSIN — Original Application (Amneal Pharmaceuticals LLC)

  The FDA approved Amneal Pharmaceuticals LLC's original application for a generic vasopressin product.

• FDA approval · 2022-07-18
  FDA Approved: VASOPRESSIN — Original Application (Amphastar Pharmaceuticals, Inc.)

  FDA approved Amphastar Pharmaceuticals' generic vasopressin product through an Original Application (ANDA). This allows marketing of a vasop…

• FDA approval · 2021-03-26
  FDA Approved: VASOSTRICT — Supplemental Application (Par Health USA, LLC)

  The FDA approved a supplemental application for VASOSTRICT (vasopressin) by Par Health USA, LLC.

• FDA approval · 2021-03-15
  FDA Approved: VASOSTRICT — Supplemental Application (Par Health USA, LLC)

  FDA approved a supplemental application for Vasostrict (vasopressin) submitted by Par Health USA, LLC.

• FDA approval · 2021-01-29
  FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved norepinephrine bitartrate injection from Sun Pharmaceutical Industries as an original-application generic product.

• FDA approval · 2018-11-07
  FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved Hikma Pharmaceuticals USA Inc.'s generic norepinephrine bitartrate injection (Original Application) as a vasopressor for treati…

• FDA approval · 2018-10-04
  FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Mylan Institutional LLC)

  FDA approved Mylan Institutional LLC's original application for norepinephrine bitartrate injections (generic) as a vasopressor to treat lif…

• FDA approval · 2017-12-21
  FDA Approved: GIAPREZA — Original Application (La Jolla Pharmaceutical Company)

  GIAPREZA (angiotensin II) was approved to increase blood pressure in adults with septic or other distributive shock.

• FDA approval · 2014-04-17
  FDA Approved: VASOSTRICT — Original Application (Par Health USA, LLC)

  The FDA granted approval for VASOSTRICT (vasopressin) through an Original Application from Par Health USA, LLC. It is approved as a vasopres…